enable injections – enable your portfolio about our mission our history executive team board of directors our awards technology delivery device delivery system human factors news careers contact us empowered effective and enabled everywhere they wear it enable your portfolio enable injections develops and manufactures onbody delivery devices that allow your patients to selfadminister high volume up to  ml andor high viscosity therapeutics utilized to bring a new product to market support lifecycle management iv to sc changes to dosing frequency reduce overall healthcare costs move from hospital to the home or to increase product differentiation our aim is to assist you in striving for a leadership position by innovating to improve the patient experience enable enhance and differentiate your portfolio biopharma advantages high volume standard container closure flexible dosing a platform technology differentiation user advantages discreet – small low profile lightweight automatic warming of refrigerated drug comfortable injection – fast or controlled minimum administration time disrupting the news “these advanced devices make possible subcutaneous injection of up to  ml of even the most viscous formulation of large doses to enable or enhance and differentiate injectable therapies” delivery device – enable injections about our mission our history executive team board of directors our awards technology delivery device delivery system human factors news careers contact us technology  the onbody delivery device quick links delivery device delivery system human factors the enable injector is designed to provide the user with a safe simple and discreet device that provides a controlled and comfortable flow of drug at a rate that adapts to the user the injector design is based on over  years of research in minimizing injection pain with numerous human factors studies conducted the enable injector incorporates a unique ‘pause function’ that allows the user to pause the injection at any time there are several sizes up to  ml  ml  ml  ml  ml and  ml capacity all injectors follow the simple steps shown below step  remove injector from transfer system and place on skin adhesive backing is automatically exposed step  remove the safety tab tab can be removed in any direction step  press button needle is automatically inserted controlled flow of drug begins gauge in window shows injection progress step  remove and dispose of the device button automatically retracts needle and locksout audibletactilevisible and discrete endofdose indication needle is never exposed enable injections and flex partner for production of wearable high volume injectors  thestreet action alerts plus access aapjim cramers best stocks for charitable trust portfoliomost recent trade alert investing rules trading commandments real money access rm rules of investingjim cramers best stocks for  commandmentsstressed out stockscramers blog cramer mad money etfs futures markets much more banksbiotechretailtechpersonal financeretirementfinancial advisor centerhow to spendoptionsfixed incomevideo privacy policyterms of use 99 thestreet inc all rights reserved djia nasdaq sp  market data updated sign in your memberships your account account preferences alerts newsletters subscribe logout subscribe access insights and guidance from our wall street pros find the product thats right for you action alerts plus action alerts options daily swing trade income seeker quant ratings real money real money pro stocks under  top stocks trifecta stocks real money pro portfolio chairmans club compare all chatter on the street enable injections and flex partner for production of wearable high volume injectors business wire feb    am est enable injections inc the developer and manufacturer of wearable medical devices that enable easy patient selfadministration of high volume injectable drugs has entered into a product development and manufacturing partnership with flex nasdaqflex the global sketchtoscale solutions company that designs and builds intelligent products for a connected world as part of the deal enable injections and flex will collaborate on the design development and production of customized wearable injector systems for pharmaceutical company products and clinical trials effective design of wearable medical devices requires that we innovate on multiple fronts pushing the boundaries of wearable technology medical device development and manufacturing processes said paul humphries president of high reliability solutions at flex with their track record of quality and innovation enable injections is an ideal partner in this process we are proud to have been selected as enable injections manufacturing partner and thrilled to be helping bring innovative high quality wearable medical devices to the pharmaceutical and biotech industries according to enable injections the companys novel injectors  based on painfree injection technology and preferred by patient panels  provide customers with numerous advantages including subcutaneous delivery of up to  ml doses of high volume andor viscous biologics ability to monitor compliance and capture data utilizing optional bluetooth connectivity and a mobile app to provide a connected healthcare solution passive warming of drug product eliminating the minute wait for refrigerated vials to reach room temperature automated mixing and reconstitution reducing formulation time and drug development costs use of standard vials cartridges and syringes and existing container closures facilitation of inhome therapy reducing healthcare system costs flex is the recognized leader in high volume manufacturing of bodyworn injection systems we very much look forward to partnering with flex to satisfy pharmaceutical and biotech company requirements for high reliability high volume manufacturing said michael d hooven enable injections president and ceo if you liked this article you might like jim cramer reveals the terrific technology company partnering with nike nike was upgraded by morgan stanley jim cramer jul    am edt fedex apple are on a roll explains jim cramer theres been a delayed response to the good news for some companies jim cramer jun   9 pm edt cramer these stocks are playing catchup theres been a delayed response to the good news for some companies jim cramer jun    pm edt nike and adidas could be on verge of unleashing something financially gamechanging a morgan stanley analysis predicts supply chain improvements could transform sneaker stocks laura berman jun   9 pm edt trending starbucks shares are crashing go out and buy heres how you can get a decent job at amazon on august  teslas model  arrives on friday  heres everything you need to know about this overhyped ride amazons disappointment sinks wall street dont buy the hype twitter isnt dead yet att verizon prove their worth advertising partners 99 thestreet inc all rights reservedaction alerts plus is a registered trademark of thestreet inc compare brokers news – enable injections about our mission our history executive team board of directors our awards technology delivery device delivery system human factors news careers contact us news upcoming events jul     th annual congress of international drug discovery science  technologyosaka japan oct     wearable drug delivery devices conferencelondon uk oct 9    partnership opportunities in drug delivery poddboston ma nov     the universe of prefilled syringes and injection devicesvienna austria nov   9  9th annual piper jaffray healthcare conferencenew york ny jan    drug delivery partnershipspalm beach gardens fl articles enable injections finds fertile environment for growth in greater cincinnati july    redi cincinnati beyond connectivity enable  flex announce the enable smart device june   ondrugdelivery combination products enable injections largevolume wearable injector solves the problem of biologics delivery may    mmm enable injections inc largevolume injectors differentiate combination products may   drug development  delivery marketing outside the box may   pharmatimes solving the problem of biologic delivery large volume wearable injectors apr    biotechblog expiring biologics not so fast mar    pharmaleaders my other life with mike hooven mar    pm disruptive delivery technology partnerships are key to pharmaceutical life cycle management jan    drug development  delivery enable injections a patientfriendly device for the selfadministration of biologics dec    medtech strategist these are the cincinnati startups to watch in  dec    cincinnati business courier disruptive delivery technology partnerships nov  pm sophisticated connected wearables boosting biologics ’ compliance value  patient satisfaction oct    drug development  delivery pharma company innovation  lifecycle management delivery devices as the new key to product success sep 9   ondrugdelivery delivery science can play a significant role in patientfocused innovation while reducing drug prices health system costs aug    controlled release society industry perspectives jul    drug development  delivery news releases enable injections introduces first multivialmultisyringe biologics delivery system for several pharma partners at bio  jun 9   pr newswire  innovation  technology award winner enable injections apr    cincinnati business courier cincytech  here we grow nov  cincytech enable injections closes m series a financing led by ori healthcare oct    business wire enable injections completes cincinnati manufacturing facility for onbody delivery systems jun    drug development  delivery cincytech predicts  new jobs with m fund apr    cincinnaticom enable injections and flex partner for production of wearable high volume injectors feb    businesswire clinical trials enable injections completes its firstinhuman wearable injector pilot trial sep    business wire enable injections inc  company profiles  company profile  blank design subscriptions  contact us article guidelines  about us news back issues executive interviews media planner resource directory events search enable injections inc posted date       enable injections inc  e sharon road cincinnati oh  t    e infoenableinjectionscom   w wwwenableinjectionscom     meeting the rising need in delivering biological treatments enable injections’ technology is designed to meet the delivery needs of biologics treatments which comprise an increasing focus in product development the enable injections onbody delivery system can address the new set of challenges and deliver these high volume often highly viscous therapeutics to the patient in an effective safe and affordable means that cannot be addressed by legacy injection systems enable injections is introducing their line of a new class of devices to deliver these drugs subcutaneously by patients at home with the potential to help revolutionize treatment of cancer autoimmune deficiencies blood disorders and a range of other conditions enable injections intends to create market leading biologics delivery devices that meet the most pressing needs of pharmaceutical companies while enabling easy patient selfadministration   the enable onbody delivery system founded by medical device veterans enable injections develops and manufactures medical devices for convenient selfadministration of high volume subcutaneous injectable drugs the enable onbody delivery system obds consists of a single injector up to  ml  ml   ml  ml and  ml capacity  and associated transfer system syringe vial or fullyautomated reconstitution that intuitively transfers drug from the original primary container closure to the injector therefore the system does not require any change to the primary container ensuring further drug stability studies and new product or assembly lines are not required   enable’s solution for pharma the enable obds provides the potential solution for delivery of high volume subcutaneous products to enable enhance and differentiate the biopharmaceutical portfolio this can be achieved through differentiating the new innovative pipeline of pharma – such as with products of similar mechanisms of action – by improving patient compliancepersistence to therapy or through life cycle management of current biological drug products for relevant products life cycle management opportunities supported by use of the enable system include facilitating the delivery of intravenous formulations to subcutaneous delivery or by reducing the dose frequency of current subcutaneous formulations through increasing the dose volume   enable’s solution for patients  healthcare the enable obds is designed for the patient to selfadminister at home potentially replacing infusions at a health facility and improving cost effectiveness of biological therapies additionally the injector is designed to have a friendly looking appeal to reduce anxiety provide the smallest profile and size for highest delivery volume promote user mobility and be simpleintuitive to use popularitythis record has been viewed 99 times         news back issues executive interviews media planner resource directory events search copyright    drug development  delivery all rights reserved privacy policy  terms and conditions loading enable injections inc company profile  bloomberg feedback enable injections inc private company company profile sector health care industry medical equipment  devices subindustry medical devices enable injections inc develops and manufactures medical devices the company offers bodyworn injectable devices including syringe and vial transfer and fullyautomated reconstitution systems enable injections serves customers in the united states corporate information address  east sharon road cincinnati oh  united states phone  fax  web url wwwenableinjectionscom from the web key executives michael d hooven mike presidentceo sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext9 personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft enable injections takes on m from ori healthcare  wsj dow jones a news corp companynews corp is a network of leading companies in the worlds of diversified media news education and information servicesdow jonesbarronsbigchartsdjxdow jones newswiresfactivafinancial newsmansion globalmarketwatchnewsplusprivate marketsrisk  compliancewsj conferencewsj prowsj videowsjcomnews corpbig decisionsbusiness spectatorcheckoutharper collinsnew york postproptigerrearealtorcomstoryfulthe australianthe sunthe timessubscribe nowsign inthe wall street journalsearchsearch→ ‘skinny’ repeal of obamacare fails in senate us gdp advanced  in second quarter senators move to block trump from ousting sessions scaramucci erupts over priebus and leakers big oil posts healthy profits russia to kick out some us diplomats over sanctions pakistan prime minister removed from office over panama papers tax report bad news if you make  to  higher taxes for many sapphire reserve cards not so rewarding for jp morgan fans of rooster teeth flock to live events cheap eggs flood us grocery stores can chewing gum boost your golf game globalization in retreat china’s next target us microchip hegemony the ahed spain has a debt problem and so now it has a zorro problem small medium large save article sign in to save subscribe to wsj new money enable injections takes on m from ori healthcare by brian gormley brian gormley the wall street journal biographybrian gormley briangormleywsjcom oct    pm et enable injections inc which has developed a wearable product for injecting biological drugs said it has closed a  million series a round led by ori healthcare fund cincytech cintrifuse cincinnati children’s hospital medical center and ohio innovation fund also participated cincinnatibased enable said its lightweight device to read the full story subscribe sign in most popular videos sen graham the skinny bill is a disaster dan neil drives vws atlas who and what is covered by medicaid how luxury home builders build for themselves big six leave border adjustment out of tax principles most popular articles scaramucci erupts over priebus and leakers bad news if you make  to  higher taxes for many opinion trump is woody allen without the humor stop saying tom brady is old hanging nude paintings in your home so out they’re in popular on wsj most popular videos sen graham the skinny bill is a disaster dan neil drives vws atlas who and what is covered by medicaid how luxury home builders build for themselves big six leave border adjustment out of tax principles most popular articles scaramucci erupts over priebus and leakers bad news if you make  to  higher taxes for many opinion trump is woody allen without the humor stop saying tom brady is old hanging nude paintings in your home so out they’re in save article sign in to save subscribe to wsj text size small medium large print facebook twitter whatsapp sms copy link enable injections completes cincinnati manufacturing facility for on body delivery systems english français register sign in enable injections completes cincinnati manufacturing facility for on body delivery systems wearable high volume injectors clinical trials to begin june    et  source enable injections llc photorelease mlinjectormomabdomenplacementjpg for teams developing injectable biologics and high volume drugs up to  ml new advanced wearable delivery technology automates lyophilization and makes development of stable bioavailable clinically relevant formulations easier faster and less costly san francisco june   globe newswire  enable injections inc the developer of wearable medical devices that enable easy athome selfadministration of high volume injectable drugs and biologics opens its new cincinnati manufacturing facility this month the company announced today at the bio meeting in san francisco a photo accompanying this announcement is available at httpwwwglobenewswirecomnewsroomattachmentngebaacdaaaebed9b enable injections’ advanced on body delivery systems obds – based on injection technology associated with a more comfortable experience and preferred by patient panels – provide pharmaceutical and biotech companies with numerous advantages including subcutaneous delivery of up to  ml doses of high volume andor viscous biologicsquick passive warming of drug product while device fills eliminating the minute wait time for refrigerated vials to reach room temperatureallows use of existing container closures including standard vials cartridges and syringesautomated mixing and reconstitution available reducing formulation time and drug development costsfacilitation of inhome therapy significantly reducing healthcare system costsability to monitor compliance and capture data utilizing optional bluetooth connectivity and a mobile app to provide a connected healthcare solution “our newly certified facility with its clean room warehousing capacity and exceptional process flow rivals any pharmaceutical company manufacturing facility” said operations manager and pharmaceutical industry veteran tom docherty small scale obds manufacturing has begun at the ohio facility with clinical trials commencing in the near future the scalable  square foot cincinnati facility with a second clean room planned will manufacture device quantities of up to one million units in february enable injections and flex entered into a product development and manufacturing partnership for large scale builds of over a million device units “our many pharmaceutical company partners and site visitors who are considering cross labeled or copackaged product have been impressed” said eileen rogers vp of operations who previously served as senior director of operations at amylin where she also worked with eli lilly bristol myers squibb and astrazeneca “we look forward to continuing to work with partners to develop patientfriendly drug delivery technology that shows great potential to add value to the healthcare system by boosting compliance while lowering costs” said enable injections ceo michael hooven please visit us at bio booth  about enable injections founded in february  by medical device industry veterans cincinnati ohbased enable injections develops and manufactures wearable devices that allow easy comfortable patient selfadministration of high volumeviscosity drugs for pharmaceutical and biotechnology industry investigational use the enable bodyworn injector utilizes any standard container closure system including syringe or vial automatically warms and can automatically mix lyophilized solutions wwwenableinjectionscommedia contact edna kaplan 99 kaplankogsprcom related articles other press releases by enable injections llc profile enable injections llc   subscribe via rss  subscribe via atom  javascript cincinnati ohio united states contact data media contact edna kaplan 99 kaplankogsprcom contact with a reader account its easy to send email directly to the contact for this release sign up today for your free reader account already have an account log in here media files mlinjectormomabdomenplacementjpg jpeg   x  image url  copy the link below for teams developing injectable biologics and high volume drugs up to  ml new advanced wearable delivery technology automates lyophilization and makes development of stable bioavailable clinically relevant formulations easier faster and less costly formats available original large medium small enable injections llc logo logo url  copy the link below formats available original medium small tags enable injections wearable high volume injectors biologics drug delivery san francisco cincinnati pharmaceuticals newswire distribution network  management home newsroom rss feeds legal contact us about us globenewswire a nasdaq company is one of the worlds largest newswire distribution networks specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media investment community individual investors and the general public contact us corporate headquarters  rosecrans avenue suite  el segundo ca 9 phone   fax   european headquarters woolgate exchange  basinghall street london ecv ha uk phone     globenewswire inc all rights reserved